DNLI DENALI THERAPEUTICS INC

Ownership history in Engineers Gate Manager LP  ·  18 quarters on record

This page tracks every 13F SEC filing in which Engineers Gate Manager LP reported a position in DENALI THERAPEUTICS INC (DNLI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.05% (2023 Q1)
Avg. % of fund
0.02%
First filed
2019 Q4
Last filed
2025 Q3
Quarters held
18
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 69,216 -46,885 -40.4% 0.01% $1.0M $14.52
2025 Q2 ADDED 116,101 +98,903 +575.1% 0.02% $1.6M $13.99
2025 Q1 REDUCED 17,198 -36,160 -67.8% 0.00% $234K $13.60
2024 Q4 ADDED 53,358 +42,228 +379.4% 0.02% $1.1M $20.38
2024 Q2 REDUCED 11,130 -20,226 -64.5% 0.01% $258K $23.22
2024 Q1 ADDED 31,356 +18,684 +147.4% 0.02% $643K $20.52
2023 Q4 REDUCED 12,672 -10,937 -46.3% 0.01% $272K $21.46
2023 Q3 REDUCED 23,609 -8,211 -25.8% 0.02% $487K $20.63
2023 Q2 REDUCED 31,820 -24,965 -44.0% 0.04% $939K $29.51
2023 Q1 ADDED 56,785 +39,465 +227.9% 0.05% $1.3M $23.04
8 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    DNLI price (monthly, adj. close)
← Back to Engineers Gate Manager LP Holdings